HIND
HIND
NASDAQ · Pharmaceuticals

Vyome Holdings Inc

$2.07
+0.14 (+7.25%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +823.7% upside
Low Target $13.94
Average Target $19.12
High Target $23.15
Current Price $2.07
Current
$2.07
Target
$19.12
$13.94 $19.12 avg $23.15
Scenario Analysis
Bear Case
$13.94
573.4%
Low target
Base Case
$19.12
+823.7%
Avg target
Bull Case
$23.15
+1,018.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.56
-78.3% from high
52-Week Low
$1.75
+18.3% from low
Target vs 52W High
$19.12
+100.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.8%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.1%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.0%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.6%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +187.5%